SINGAPORE - Singapore investment firm Temasek Holdings has led a US$25 million investment round in Integra Holdings, an investment company focused exclusively on life science innovations originating from the Hebrew University of Jerusalem.
Temasek, which led the round with an investment of US$15 million, was joined by Arie Capital with an initial investment of US$2 million. The Israeli Teachers' and Kindergarten's Study Funds, one of Integra's existing shareholders, also participated in the round.
The funds raised will be used to advance Integra Holdings' existing portfolio companies and to create new companies, based on promising technologies originating from the Hebrew University of Jerusalem, Integra said in a statement on Wednesday.
Integra chief executive Liana Patt noted that this strategic investment will reinforce the global recognition of the Hebrew University's exceptional contribution to life science innovations and Integra's robust and growing portfolio.
The firm's chief financial officer Lior Buchman added: "This latest round of investment will allow more breakthrough discoveries to realize their potential and reach a broader community of entrepreneurs, investors and industry partners."
Temasek has a net portfolio value of S$275 billion as at March 31, mainly in Singapore and the rest of Asia.